Climb Bio, Inc.
CLYM • XNAS
Climb Bio, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Aoife Brennan BCh MMSc, with a market cap of $384.5M.
Market Cap$384.5M
Employees11.0
CEOAoife Brennan BCh MMSc
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Climb Bio, Inc. FAQ
Common questions about Climb Bio, Inc.
Climb Bio, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
Climb Bio, Inc. has approximately 11 employees.